Previous close | 2.9115 |
Open | 2.8300 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 2.8250 - 2.8300 |
52-week range | 1.8858 - 4.4700 |
Volume | |
Avg. volume | 25,757 |
Market cap | 678.348M |
Beta (5Y monthly) | 1.16 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | 14 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
HEALWELL completes acquisition of a majority stake of Pentavere, a healthcare artificial intelligence (AI) company who has built a best-in-class AI engine to help solve some of healthcare’s toughest data challenges. Pentavere has developed and validated leading capabilities in data structuring and abstraction; a key capability to unlocking clinical value and unmet needs for patients and providers.The Pentavere acquisition adds revenue, new pharmaceutical and life sciences customers, access to ho
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce series of strategic investment developments that highlight its leadership in fostering innovation within the digital health technology sphere.
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce the launch of its latest AI powered product, WELL AI Inbox Admin.